US company acquired NovaUCD-based biotech firm for an undisclosed sum in July
NovaUCD-based company has point-of-care in-vitro diagnosis system known as RapiPlex
Diagnostic platform RapiPlex due to arrive on market in about two years’ time
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices